BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 217527)

  • 1. The triad of hemochromatosis, hepatoma and erythrocytosis.
    Raphael B; Cooperberg AA; Niloff P
    Cancer; 1979 Feb; 43(2):690-4. PubMed ID: 217527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemochromatosis, hepatoma, erythrocytosis, and erythropoietin.
    Lizzi FA; Tartaglia AP; Adamson JW
    N Y State J Med; 1973 May; 73(9):1098-100. PubMed ID: 4348807
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatoma, erythrocytosis and increased serum erythropoietin developing in long-standing hemochromatosis.
    Scott D; Theologides A
    Am J Gastroenterol; 1974 Mar; 61(3):206-11. PubMed ID: 4363553
    [No Abstract]   [Full Text] [Related]  

  • 4. [Erythrocytosis in patients with hepatocarcinoma in alcoholic cirrhosis: ectopic production of erythropoietin?].
    Giovanardi P; Sacchetti C; Cameroni P; Grandi M
    Recenti Prog Med; 1998 May; 89(5):250-2. PubMed ID: 9676132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma and erythrocytosis.
    Davidson CS
    Semin Hematol; 1976 Apr; 13(2):115-9. PubMed ID: 180613
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatocellular carcinoma in a patient with hereditary hemochromatosis and noncirrhotic liver. A case report.
    Köhler HH; Höhler T; Küsel U; Kirkpatrick CJ; Schirmacher P
    Pathol Res Pract; 1999; 195(7):509-13. PubMed ID: 10448668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocytosis caused by an erythropoietin-producing hepatocellular carcinoma.
    Matsuyama M; Yamazaki O; Horii K; Higaki I; Kawai S; Mikami S; Higashino M; Oka H; Nakai T; Inoue T
    J Surg Oncol; 2000 Nov; 75(3):197-202. PubMed ID: 11088052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: immunohistochemical evidence.
    Sakisaka S; Watanabe M; Tateishi H; Harada M; Shakado S; Mimura Y; Gondo K; Yoshitake M; Noguchi K; Hino T
    Hepatology; 1993 Dec; 18(6):1357-62. PubMed ID: 7694895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma associated with erythrocytosis. A nine year survival after successful chemotherapy and left lateral hepatectomy.
    Okazaki N; Ozaki H; Arima M; Hattori N; Kimura K
    Acta Hepatogastroenterol (Stuttg); 1979 Jun; 26(3):248-52. PubMed ID: 225917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of erythrocytosis in patients with hepatocellular carcinoma.
    Hwang SJ; Lee SD; Wu JC; Chang CF; Lu CL; Tsay SH; Lo KJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 May; 53(5):262-9. PubMed ID: 7518732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression of erythropoietin in hepatocellular carcinoma.
    Muta H; Funakoshi A; Baba T; Uike N; Wakasugi H; Kozuru M; Jimi A
    Intern Med; 1994 Jul; 33(7):427-31. PubMed ID: 7524823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma associated with a rare combination of polycythemia and chronic thyroiditis.
    Watanobe H
    Hepatogastroenterology; 1988 Feb; 35(1):14-6. PubMed ID: 2834279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycemia and erythrocytosis associated with hepatoma.
    Bundith V; Chandraprasert S; Sriratanaban A
    J Med Assoc Thai; 1972 Feb; 55(2):110-5. PubMed ID: 4335655
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythrocytosis and hyperlipemia as manifestations of hepatic carcinoma.
    Santer MA; Waldmann TA; Fallon HJ
    Arch Intern Med; 1967 Dec; 120(6):735-9. PubMed ID: 4293747
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythrocytosis in hepatocellular cancer.
    Jacobson RJ; Lowenthal MN; Kew MC
    S Afr Med J; 1978 Apr; 53(17):658-60. PubMed ID: 209568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Erythrocytosis associated with hepatocellular carcinoma. Two case reports].
    Argumanis E; Quispe D; Ruiz E
    Rev Gastroenterol Peru; 2002; 22(1):84-7. PubMed ID: 11961573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression of mutant erythropoietin in hepatocellular carcinoma.
    Funakoshi A; Muta H; Baba T; Shimizu S
    Biochem Biophys Res Commun; 1993 Sep; 195(2):717-22. PubMed ID: 8396923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatomyositis and erythrocytosis associated with hepatocellular carcinoma.
    Cheng TI; Tsou MH; Yang PS; Sung SM; Chuang VP; Sung JL
    J Gastroenterol Hepatol; 2002 Nov; 17(11):1239-40. PubMed ID: 12453288
    [No Abstract]   [Full Text] [Related]  

  • 19. [Erythrocytosis in primary cancer of the liver].
    Zlatkina AR; Shcherbak EM
    Probl Gematol Pereliv Krovi; 1970 Jun; 15(6):55-6. PubMed ID: 4319483
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolyl-4-Hydroxylase 2 Potentially Contributes to Hepatocellular Carcinoma-Associated Erythrocytosis by Maintaining Hepatocyte Nuclear Factor-4α Expression.
    Sun W; Kosyna FK; Jelkmann W; Depping R
    Cell Physiol Biochem; 2015; 37(6):2257-64. PubMed ID: 26624507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.